FDC Ltd FDC
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ₹388.60
- Day Range
- ₹386.20–393.70
- 52-Week Range
- ₹312.95–466.85
- Bid/Ask
- ₹388.65 / ₹388.70
- Shares Outstanding
- 162.81M
- Market Cap
- ₹63.24B
- Volume/Avg
- 143,843 / 233,701
Key Statistics
- Price/Earnings (Normalized)
- 20.85
- Price/Sales
- 2.76
- Dividend Yield (Trailing)
- 1.29%
- Dividend Yield (Forward)
- 2.57%
- Dividend Payment Schedule
- Feb
- Total Yield
- 1.29%
Company Profile
FDC Ltd is principally engaged in the business of manufacturing and trading pharmaceutical products. It has its presence in numerous therapeutic segments including anti-infectives, gastrointestinal treatments, ophthalmics, vitamins, minerals, dietary supplements, cardiovascular solutions, anti-diabetics, and others. The company's different pharmaceutical products are marketed through brands such as Electral, Enerzal, Zifi, Zocon, Vitcofol, MumMum 1, Victofol Injection, Simyl MCT and many others. Geographically, the company derives maximum revenue from India.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 7,076
- Website
- https://www.fdcindia.com
Valuation
|
Metric
|
FDC
|
|---|---|
Price/Earnings (Normalized) | 20.85 |
Price/Book Value | 2.37 |
Price/Sales | 2.76 |
Price/Cash Flow | 21.30 |
Price/Earnings
FDC
Financial Strength
|
Metric
|
FDC
|
|---|---|
Quick Ratio | 1.81 |
Current Ratio | 2.76 |
Interest Coverage | 97.12 |
Quick Ratio
FDC
Profitability
|
Metric
|
FDC
|
|---|---|
Return on Assets (Normalized) | 9.65% |
Return on Equity (Normalized) | 11.42% |
Return on Invested Capital (Normalized) | 11.47% |
Return on Assets
FDC
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| LOCK|lSsC$?B> | LOCK|@Hf? | $73B | |||
| Teva Pharmaceutical Industries Ltd
TEVA
| LOCK|kx<@nCDM | LOCK|w@<kx | $50B | |||
| Haleon PLC ADR
HLN
| LOCK|kq^B^$r | LOCK|@R< | $38B | |||
| Zoetis Inc Class A
ZTS
| LOCK|?!!D<%&t | LOCK|qk | $34B | |||
| Viatris Inc
VTRS
| LOCK|?jLr>rS | LOCK|H$j | $22B | |||
| Elanco Animal Health Inc
ELAN
| LOCK|%SG | LOCK|!yL | $12B | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| LOCK|lY@&@@S | LOCK|b#% | $12B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
| LOCK|hnLJw#h | LOCK|YbK | $6B | |||
| Prestige Consumer Healthcare Inc
PBH
| LOCK|Lj>x^%H | LOCK|t!Kp% | $2B | |||
| Perrigo Co PLC
PRGO
| LOCK|RcbRX?Z | LOCK|<> | $2B |
United States